Amgen to spend $900M to expand Ohio drugmaking plant

hapabapa Amgen ( NASDAQ: AMGN ) will invest an additional $900M to expand a biomanufacturing plant in New Albany, Ohio. The move will also add hundreds of new jobs, Bloomberg reported. The currently 270,000-sq-foot facility first opened in March 2024.

It is considered a final product.